These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34188746)

  • 21. Favorable effects of microneedling on long-standing androgenetic alopecia in an elderly man: A case report.
    Fujita J
    J Cosmet Dermatol; 2021 Feb; 20(2):588-590. PubMed ID: 32500595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of androgenetic alopecia.
    Tosti A; Camacho-Martinez F; Dawber R
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
    Roberts J; Desai N; McCoy J; Goren A
    Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-delivery of minoxidil and tocopherol acetate ethosomes to reshape the hair Follicular Microenvironment and promote hair regeneration in androgenetic alopecia.
    Yan A; Ruan R; Zhu X; Qiang W; Guan Y; Yu Q; Sun H; Liu M; Zhu H
    Int J Pharm; 2023 Nov; 646():123498. PubMed ID: 37820942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
    Ghonemy S; Alarawi A; Bessar H
    J Dermatolog Treat; 2021 Mar; 32(2):236-241. PubMed ID: 31403367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of oral minoxidil in female androgenetic alopecia.
    Vastarella M; Cantelli M; Patrì A; Annunziata MC; Nappa P; Fabbrocini G
    Dermatol Ther; 2020 Nov; 33(6):e14234. PubMed ID: 32851744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical minoxidil therapy for hair regrowth.
    Rumsfield JA; West DP; Fiedler-Weiss VC
    Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review.
    Pietrauszka K; Bergler-Czop B
    Postepy Dermatol Alergol; 2022 Jun; 39(3):472-478. PubMed ID: 35950120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trace elements content and hormonal profiles in women with androgenetic alopecia.
    Skalnaya MG; Tkachev VP
    J Trace Elem Med Biol; 2011 Jan; 25 Suppl 1():S50-3. PubMed ID: 21167696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgenetic alopecia.
    Piraccini BM; Alessandrini A
    G Ital Dermatol Venereol; 2014 Feb; 149(1):15-24. PubMed ID: 24566563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Trichoscopic Findings in Androgenetic Alopecia and the Disease Severity.
    Ummiti A; Priya PS; Chandravathi PL; Kumar CS
    Int J Trichology; 2019; 11(3):118-122. PubMed ID: 31360040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study.
    Masoud F; Alamdari HA; Asnaashari S; Shokri J; Javadzadeh Y
    Dermatol Ther; 2020 Nov; 33(6):e14467. PubMed ID: 33112463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride.
    Chandrashekar BS; Nandhini T; Vasanth V; Sriram R; Navale S
    Indian Dermatol Online J; 2015; 6(1):17-20. PubMed ID: 25657911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiandrogenic Therapy with Ciproterone Acetate in Female Patients Who Suffer from Both Androgenetic Alopecia and Acne Vulgaris.
    Coneac A; Muresan A; Orasan MS
    Clujul Med; 2014; 87(4):226-34. PubMed ID: 26528029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
    Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
    J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Efficacy and Safety of Dr. SKS Hair Booster Serum (a Cocktail of Micronutrients and Multivitamins) in Adult Males and Females With Androgenetic Alopecia: An Open-Label, Non-randomized, Prospective Study.
    Khare S
    Cureus; 2023 Apr; 15(4):e37424. PubMed ID: 37182050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.